1. Home
2. Raw materials
3. Lipid-lowering agents
4. Fibrates

Fibrates

Fibrates are a subcategory of pharmaceutical active pharmaceutical ingredients (APIs) used in the treatment of various cardiovascular disorders. These medications primarily target lipid metabolism and are commonly prescribed to manage conditions such as hyperlipidemia and dyslipidemia.

Fibrates work by activating peroxisome proliferator-activated receptors (PPARs) in the liver, which regulate genes involved in lipid metabolism. By stimulating PPARs, fibrates enhance the breakdown of triglycerides and increase the production of high-density lipoprotein (HDL) cholesterol, commonly referred to as "good cholesterol." Simultaneously, they reduce low-density lipoprotein (LDL) cholesterol levels, also known as "bad cholesterol," and decrease the levels of total cholesterol.

The most commonly used fibrates include gemfibrozil, fenofibrate, and bezafibrate. These drugs are available in various formulations such as tablets and capsules for oral administration. Fibrates are typically prescribed in combination with dietary modifications and lifestyle changes to optimize their effectiveness.

Although fibrates are generally well-tolerated, they may have some side effects, including gastrointestinal disturbances, liver enzyme abnormalities, and muscular complications. Therefore, close monitoring of patients is necessary during fibrates therapy.

In conclusion, fibrates are a crucial subcategory of pharmaceutical APIs utilized to manage lipid disorders. By modulating lipid metabolism through PPAR activation, these medications effectively regulate cholesterol levels and improve cardiovascular health. However, medical supervision and regular monitoring are essential to ensure their safe and effective use.